Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines Journal:Investigational New Drugs | 2010 | 319 | ||
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | 75 | ||
2011 | ||||
2011 | 200 | |||
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters | 2014 | 93 | ||
Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and β 2-tubulin for nasopharyngeal carcinoma Journal:Archives of Pathology and Laboratory Medicine | 2008 | |||
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro Journal:International Journal of Cancer | 2009 |